Role of neutrophil derived oxidants and elastase in lipopolysaccharidemediated renal injury. Gram-negative bacterial sepsis is frequently associated with acute renal failure but the specific effects of lipopolysaccharide (LPS) and other bacterial products on kidney function are not known. Since either LPS or formyl-methionyl-leucyl-phenylalanine (FMLP)-a chemotactic peptide from bacterial cell walls-activate neutrophils (PMN) to release a number of potentially toxic factors in vitro, we determined the effect of adding PMN with LPS and/or FMLP to isolated perfused rat kidneys. Isolated rat kidneys perfused with LPS alone or LPS and normal PMN had normal glomerular filtration rates (GFR) and tubular Na reabsorption (TNa). Kidneys perfused with FMLP alone or FMLP and normal PMN also had normal GFR and TNa.
vated PMN release a number of factors which are potentially nephrooxic. These include toxic products of oxygen metabolism (02 metabolites) as well as proteinases such as neutrophil elastase and metalloproteinases [15, 16] . Despite this potential interaction between LPS and PMN, the role of PMN in acute renal failure associated with gram negative sepsis has not been carefully evaluated. Moreover, while synergism between neutrophil elastase and oxidants has been described in other systems [16, 171 , this type of additive interaction between neutrophil derived oxidants and proteinases has not been described in the kidney. We undertook this study, therefore, to determine the role of PMN in bacterial-product mediated renal injury. To address this issue, we utilized the isolated perfused rat kidney. In this simple system, the specific effects of PMN activated with bacterial products-LPS and/or formyl-methionylleucyl-phenylalanine (FMLP) can be determined in the absence of circulating hormonal or other factor which would otherwise complicate elucidation of the role of PMN. Using this strategy, we obtained results which support the premise that bacterial products activate PMN to injure kidneys by both 02 metaboliteand elastase-mediated mechanisms.
Methods

Sources of reagents
The following reagents were used in this study: albumin (fraction V bovine, Reheis Chemical, Phoenix, Arizona, USA); hydroxyl ['4C] methyl inulin (Amersham, Arlington Heights, Illinois, USA); dimethylthiourea (DMTU) (Alfa Products, Danvers, Massachusetts, USA); phorbol myristate acetate (PMA), catalase (CAT) (bovine liver, 2,000 U/mg protein), FMLP, elastase (Type IV Pancreatic 70 U/mg protein (Sigma Chemical, St. Louis, Missouri, USA); LPS (#201 Escherichia Coil 0111: B4, List Biological Laboratory, Inc., Campbell, California, USA); Eglin C (Ciba-Geigy, Switzerland) [17, 18] .
Perfusion of isolated, rat kidneys Perfusion of the isolated rat kidney was conducted according to Nishiitsutsuji-Uwo, Ross and Krebs [19] as modified by Little and Cohen [20] and previously described in our laboratory [21] . Briefly, after the right renal artery was cannulated, the kidney was transferred to a perfusion chamber and perfused using a pulsatile pump at a constant mean arterial pressure (distal to the tip of the cannula) of 100 mm Hg. Following a 15-minute equilibration period, three urine collections and perfusion samples were obtained at 15 minute intervals. Perfu- Preparation of neutrophils Neutrophils were purified from human blood anticoagulated with sodium citrate (0.38%). Cells were separated by sedimentation and centrifugation and then were resuspended in plateletpoor plasma, diluted 1:4 with 6% dextran (Pharmacia Fine Chemicals, Piscataway, New Jersey, USA) in saline. Erythrocytes were separated from leukocytes by sedimentation. The leukocyte-rich supernatant was aspirated, underlaid with Protocol III was designed to determine the role of 02 metabolite scavengers in kidneys exposed to PMN plus LPS and FMLP. Isolated kidneys were exposed to PMN plus LPS and FMLP in the presence of no additions (N = 5) or DMTU (15 mM, N = 6) or CAT (200 U/ml, N 6).
Protocol IV was designed to determine the contribution of neutrophil elastase to injury in kidneys exposed to PMN plus LPS and FMLP. For these studies, the non-oxidizable neutrophil elastase inhibitor Eglin C [17, 181 was utilized. To determine the specificity of Eglin C, kidneys were perfused with elastase (2.8 U/ml, N = 3 and 5.6 U/mI, N = 4), or elastase and Egiin C (2 MM) together (N = 6) or elastase plus CAT (N = 4) or elastase plus DMTU (N = 4). In additional studies, kidneys were exposed to PMN with PMA (10 ng!ml) in the presence of no additions (N = 5), Eglin C (N = 5) or CAT (N = 6). In the final group of perfusions, isolated kidneys were exposed to PMN plus LPS and FMLP with no additions (N = 6) or Eglin C (N = 6) or Eglin C plus CAT (N = 6).
Statistical analyses
Statistical analyses were performed using one-way analysis of variance in conjunction with Scheffe's-test for comparison of multiple means. A P value of < 0.05 was considered significant. Data were expressed as means SEM.
Results
Figure 1 shows the effect of addition of PMN, LPS or FMLP to isolated perfused kidneys. During the 60 minutes of perfu- To determine if decreases in renal function in kidneys exposed in PMN in the presence of LPS and FMLP were caused by 02 metabolites, 02 metabolite scavengers, catalase or DMTU, were included in the perfusate. In earlier studies, we found that the concentrations of CAT and DMTU used in these studies prevented renal dysfunction caused by PMN stimulated with PMA, a known agonist of 02 metabolite release by PMN [221. Figure 3 shows that either CAT or DMTU resulted in small, but statistically insignificant, increases in both GFR and TNa compared to kidneys perfused without additions. Addition of CAT or DMTU alone during perfusion did not alter kidney function.
To determine whether neutrophil elastase mediated decreases in renal function in kidneys perfused with PMN treated with LPS and FMLP, studies were performed with the potent non-oxidizable neutrophil elastase inhibitor, Eglin C [17, 18] . Figure 4 shows the effect of elastase on isolated kidney function. Perfusion with elastase caused time and concentration dependent decreases in GFR and TNa (but not PFR, data not Systemic administration of LPS causes renal dysfunction in vivo by unknown mechanisms which could include alterations in systemic or renal hemodynamics [3-51, activation of renal nerves [3] or alterations in circulating hormones and cytokines [3, [5] [6] [7] [8] [9] [10] . We used the isolated perfused kidney so that we could In earlier studies [22] and other [24, 251 have shown that PMN stimulated with a single agent such as PMA cause renal injury. In the current studies we were not able to demonstrate deleterious effects of LPS or FMLP and PMN. However, concentrations of LPS, which by themselves or with PMN did not injure kidneys, appeared to enhance the injurious effect of FMLP-treated PMN. A similar phenomenon is observed in vitro. Under these conditions, LPS appears to enhance the release of a number of PMN products. For example, concentrations of LPS which do not cause oxidant or leukotriene B4 release, enhance the effect of formyl peptides to cause superoxide release [11] and zymogen to cause leukotriene B4 release from PMN [26] . Although the precise mechanism of PMN priming is not known, recent studies suggest that increases in cytosolic calcium are an important mediator of LPS priming of PMN for an enhanced superoxide release [27] . Although our data reveal an important role for PMN in LPS-mediated renal injury, other circulating leukocytes may also contribute to LPS injury. For example LPS stimulates monocytes to release a variety of biologically active cytokines such as tumor necrosis factor [29, 30] , which have been proposed to mediate many of the responses associated with endotoxemia [31] .
In addition our data imply that LPS injury is mediated by the effects of LPS on PMN rather than on kidney tissue. However, the possibility that LPS interacted with kidney tissue to activated PMN cannot be completely excluded since other PMN activators directly injure epithelial cells and endothelial cells [32] [33] [34] . In this scheme, LPS would injure epithelial and/or mesangial cells making them susceptible to PMN. Although we cannot exclude a subtle effect of LPS or FMLP on the kidney, our results underscore the critical importance of PMN in this model of renal failure since addition of LPS or FMLP in combination with PMN did not result in renal injury. Renal injury only occurred when PMN were exposed to both LPS and FMLP.
Activated PMN release a number of products which could potentially injure kidneys. Neutrophil derived toxins include 02 metabolites, myeloperoxidase and proteinases, such as neutrophil elastase and metalloproteinases [15, 16] . 02 metabolites from PMN can injure kidneys directly [351 and activate latent metalloproteinases which can injure kidneys [241. Myeloperoxidase can interact with circulating halides and hydrogen peroxide to cause marked increases in glomerular protein excretion [36] . Neutrophil elastase appears to be an important mediator of lung injury especially in settings where alpha-l-antiprotease inhibitors have been inactivated. For example, perfusion of isolated lungs with purified neutrophil elastase increased lung permeability but only after addition of H202 to reduce antielastolytic activity [37] . Our data suggest that neutrophil elastase can now be added to the list of PMN products which are capable of causing glomerular and tubular dysfunction since perfusion with the specific neutrophil elastase inhibitor Eglin C partially prevented LPS/FMLP/PMN-induced renal injury. Depending on the selectively of the stimulus used to activate PMN, the role of oxidants, myeloperoxidase and proteinases in renal injury may vary. For example, PMA is a relatively good stimulator of 02 metabolite release compared to its effect on proteinase release [13] . By comparison, FMLP is a relatively potent stimulus for degranulation compared to its ability to initiate 02 metabolite generation by PMN [13, 281 . LPS/FMLP, in the concentrations use in our study, appears to release both 02 metabolites and neutrophil elastase. Thus injury stimulated by PMA may be more susceptible to 02 metabolite scavengers (Fig. 5) while injury caused by LPS/FMLP (Fig. 6 ) appears to require both 02 metabolite and neutrophil elastase inhibitors for reversal.
Although both 02 metabolites and neutrophil elastase appeared to contribute to LPS/FMLP and PMN mediated renal injury, the toxic effects of LPS/FMLP/PMN on renal function could not be totally reversed by addition of either the neutrophil elastase inhibitor or oxygen metabolite scavengers alone. Instead, perfusion with both 02 metabolite scavengers and the neutrophil elastase inhibition was required to prevent LPS/ PMN renal injury. 02 metabolites and neutrophil elastase could interact to cause renal injury in several ways. Shah has shown that 02 metabolites activate latent metalloproteinases to cause glomerular basement membrane degradation [24] . This would not seem to be an important effect of 02 metabolites on neutrophil elastase since this enzyme is released in an active form and does not require further modification for function. Alternatively, 02 metabolites might enhance the action of neutrophil elastase by inactivating circulating antiproteinases 116, 37]. The major anti-elastolytic activities in serum are a1 proteinase inhibitor and a2 macroglobulin. Both of these compounds are susceptible to oxidant induced inhibition of action [16] . Thus 02 metabolites produced by PMN inactivate protective antielastolytic activities so that the toxic effect of neutrophil elastase is enhanced [16, 37] .
In earlier studies we showed that 02 metabolites generated by xanthine oxidase caused injury in reperfused ischemic kidneys [38] . Additionally, we showed that normal PMN worsened reperfusion injury by an 02 metabolite mediated mechanism [23] , The current studies expand on the possible role of 02 metabolites and suggest a possible interaction between 02 metabolites produced by ischemic kidneys and PMN activated with LPS. 02 metabolites produced by kidneys during reperfusion could enhance the deleterious effects of neutrophil elastase in much the same way in which 02 metabolites produced by LPS/FMLP-activated PMN enhance neutrophil elastase-mediated injury. This interaction may be particularly relevant to the clinical observation that renal ischemia predisposes to further renal injury in many situations, including gram-negative bacterial sepsis.
